Skip to content
Main Navigation
About us
Company profile
Our values
Our strategy
Board of directors
Senior Management
Our history
Innovation and research
Technology platform
Therapeutic areas
Scientific papers and presentations
Pipeline
Partnering
Our approach
Our partnerships
Investors
Financial reports and presentations
Share information
Analyst coverage
Major shareholders
Tax Value per Share
Financial calendar
Corporate governance
Corporate governance statements
ESG
Dividend policy
Annual general meeting
Articles of association
Safe harbour statement
Whistleblower policy
Risk management
Investor relations policy
Email alerting service
Media
News and announcements
Image library
Glossary
Careers
Life at Nykode
Meet us
Open positions
COVID trial
Search
Investors
Financial reports and presentations
Newest first
Oldest first
Presentations
Financial reports
Webcasts
Search
Reset
27/09/2022
Initial Results from the Phase 1/2 Trial of the T Cell SARS-CoV-2 Vaccine Candidate VB10.2210 – presentation
13/09/2022
H.C. Wainwright 24th Annual Global Investment Conference, September 13, 2022 – presentation
13/09/2022
H.C. Wainwright 24th Annual Global Investment Conference, September 13, 2022 – webcast
24/08/2022
1H 2022 FINANCIAL RESULTS – presentation
24/08/2022
1H 2022 FINANCIAL RESULTS – webcast
Pages:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Load more
Sorry, nothing found in this query
Privacy statement
Cookie policy
Disclaimer
